Autophagy and apoptosis in hepatocellular carcinoma induced by EF25-(GSH)2: A novel curcumin analog

PLoS ONE

Volumn 9, Issue 9, 2014, Pages

  Zhou, Tao ^a   Ye, Lili ^a   Bai, Yu ^a   Sun, Aiming ^b   Cox, Bryan ^b   Liu, Dahai ^a   Li, Yong ^a   Liotta, Dennis ^b   Snyder, James P ^b   Fu, Haian ^c   Huang, Bei ^a  

^a ANHUI UNIVERSITY   (China)

^b EMORY UNIVERSITY   (United States)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; 3,5 BIS(2 HYDROXYBENZYLIDENE)TETRAHYDRO 4H PYRAN 4 ONE; 3,5 BIS(2 HYDROXYBENZYLIDENE)TETRAHYDRO 4H PYRAN 4 ONE GLUTATHIONE CONJUGATE; AUTOPHAGY PROTEIN 5; BECLIN 1; CASPASE INHIBITOR; CHLOROQUINE; CISPLATIN; CURCUMIN; GLUTATHIONE; SHORT HAIRPIN RNA; UNCLASSIFIED DRUG; WORTMANNIN; Z VAD FMK; ANDROSTANE DERIVATIVE; ANTINEOPLASTIC AGENT; APOPTOSIS REGULATORY PROTEIN; ATG5 PROTEIN, HUMAN; BECN1 PROTEIN, HUMAN; EF25-(GSH)2; MEMBRANE PROTEIN; MICROTUBULE ASSOCIATED PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; AUTOPHAGY; CANCER CELL LINE; CANCER INHIBITION; CELL CYCLE ARREST; CELL PROLIFERATION; CELL VACUOLE; COLONY FORMATION; COMBINATION CHEMOTHERAPY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOPLASM; DNA CONTENT; DOSE RESPONSE; DRUG CYTOTOXICITY; DRUG DETERMINATION; DRUG EFFICACY; DRUG STRUCTURE; G2 PHASE CELL CYCLE CHECKPOINT; GENETIC TRANSFECTION; HEPATOMA CELL; HEPG2 CELL LINE; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; M PHASE CELL CYCLE CHECKPOINT; MALE; MONOTHERAPY; MOUSE; NONHUMAN; PROTEIN EXPRESSION; ANALOGS AND DERIVATIVES; CARCINOMA, HEPATOCELLULAR; CELL SHAPE; DRUG EFFECTS; DRUG SCREENING; GENETICS; HCT116 CELL LINE; HEK293 CELL LINE; HELA CELL LINE; LIVER NEOPLASMS; METABOLISM; PATHOLOGY; TUMOR VOLUME;

ANDROSTADIENES; ANTINEOPLASTIC AGENTS; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; AUTOPHAGY; CARCINOMA, HEPATOCELLULAR; CELL PROLIFERATION; CELL SHAPE; CURCUMIN; G2 PHASE CELL CYCLE CHECKPOINTS; HCT116 CELLS; HEK293 CELLS; HELA CELLS; HEP G2 CELLS; HUMANS; LIVER NEOPLASMS; MEMBRANE PROTEINS; MICROTUBULE-ASSOCIATED PROTEINS; TUMOR BURDEN; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84907527247     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0107876     Document Type: Article

References (41)

1. Fattovich G, Stroffolini T, Zagni I, Donato F (2004) Hepatocellular carcinoma in cirrhosis: incidence and risk factors. Gastroenterology 127: 35-50.
2. Llovet JM, Bruix J (2008) Novel advancements in the management of hepatocellular carcinoma in 2008. J Hepatol 48: 20-37.
3. Bruix J, Sherman M (2011) Management of hepatocellular carcinoma: an update. Hepatology 53: 1020-1022.
4. Bunchorntavakul C, Hoteit M, Reddy KR (2012) Staging of Hepatocellular Carcinoma. In: N Reau and F. F Poordad, editors. Primary Liver Cancer. New York: Springer Science+Business Media. pp. 161-175.
5. Aoki H, Takada Y, Kondo S, Sawaya R, Aggarwal BB, et al. (2007) Evidence that curcumin suppresses the growth of malignant gliomas in vitro and in vivo through induction of autophagy: role of Akt and extracellular signal-regulated kinase signaling pathways. Mol Pharmacol 72: 29-39.
6. Anand P, Thomas SG, Kunnumakkara AB, Sundaram C, Harikumar KB, et al. (2008) Biological activities of curcumin and its analogues (Congeners) made by man and Mother Nature. Biochem Pharmacol 76: 1590-1611.
7. Steward WP, Gescher AJ (2008) Curcumin in cancer management: recent results of analogue design and clinical studies and desirable future research. Mol Nutr Food Res 52: 1005-1009.
8. Sun A, Lu YJ, Hu H, Shoji M, Liotta DC, et al. (2009) Curcumin analog cytotoxicity against breast cancer cells: exploitation of a redox-dependent mechanism. Bioorg Med Chem Lett 19: 6627-6631.
9. Thomas SL, Zhong D, Zhou W, Malik S, Liotta D, et al. (2008) EF24, a novel curcumin analog, disrupts the microtubule cytoskeleton and inhibits HIF-1. Cell Cycle 7: 2409-2417.
10. Kasinski AL, Du Y, Thomas SL, Zhao J, Sun SY, et al. (2008) Inhibition of IkB Kinase-Nuclear Factor-kB Signaling Pathway by 3,5-Bis(2-flurobenzylidene)piperidin- 4-one (EF24), a Novel Monoketone Analog of Curcumin. Mol Pharmacol 74: 654-661.
11. Thomas SL, Zhao J, Li Z, Lou B, Du Y, et al. (2010) Activation of the p38 pathway by a novel monoketone curcumin analog, EF24, suggests a potential combination strategy. Biochem Pharmacol 80: 1309-1316.
12. O'Sullivan-Coyne G, O'Sullivan GC, O'Donovan TR, Piwocka K, McKenna SL (2009) Curcumin induces apoptosis-independent death in oesophageal cancer cells. Br J Cancer 101: 1585-1595.
13. Shinojima N, Yokoyama T, Kondo Y, Kondo S (2007) Roles of the Akt/mTOR/p70S6K and ERK1/2 signaling pathways in curcumin-induced autophagy. Autophagy 3: 635-637.
14. Yoon MJ, Kim EH, Lim JH, Kwon TK, Choi KS (2010) Superoxide anion and proteasomal dysfunction contribute to curcumin-induced paraptosis of malignant breast cancer cells. Free Radic Biol Med 48: 713-726.
15. Adams BK, Ferstl EM, Davis MC, Herold M, Kurtkaya S, et al. (2004) Synthesis and biological evaluation of novel curcumin analogs as anti-cancer and antiangiogenesis agents. Bioorg Med Chem 12: 3871-3883.
16. Hui IC, Tung EK, Sze KM, Ching YP, Ng IO (2010) Rapamycin and CCI-779 inhibit the mammalian target of rapamycin signalling in hepatocellular carcinoma. Liver international: official journal of the International Association for the Study of the Liver 30: 65-75.
17. Lu B, Ma Y, Wu G, Tong X, Guo H, et al. (2008) Methylation of Tip30 promoter is associated with poor prognosis in human hepatocellular carcinoma. Clinical cancer research 14: 7405-7412.
18. Gao J, Li X, Gu G, Sun B, Cui M, et al. (2011) Efficient synthesis of trisaccharide saponins and their tumor cell killing effects through oncotic necrosis. Bioorg Med Chem Lett 21: 622-627.
19. Tang B, Yu F, Li P, Tong L, Duan X, et al. (2009) A near-infrared neutral pH fluorescent probe for monitoring minor pH changes: imaging in living HepG2 and HL-7702 cells. J Am Chem Soc 131: 3016-3023.
20. Kuck D, Caulfield T, Lyko F, Medina-Franco JL (2010) Nanaomycin A selectively inhibits DNMT3B and reactivates silenced tumor suppressor genes in human cancer cells. Molecular cancer therapeutics 9: 3015-3023.
21. Prause M, Christensen DP, Billestrup N, Mandrup-Poulsen T (2014) JNK1 protects against glucolipotoxicity-mediated beta-cell apoptosis. PloS one 9: e87067.
22. Lin Y, Peng S, Yu H, Teng H, Cui M (2012) RNAi-mediated downregulation of NOB1 suppresses the growth and colony-formation ability of human ovarian cancer cells. Med Oncol 29: 311-317.
23. Yang CH, Yue J, Sims M, Pfeffer LM (2013) The curcumin analog EF24 targets NF-kappaB and miRNA-21, and has potent anticancer activity in vitro and in vivo. PloS one 8: e71130.
24. Yadav VR, Sahoo K, Roberts PR, Awasthi V (2013) Pharmacologic suppression of inflammation by a diphenyldifluoroketone, EF24, in a rat model of fixedvolume hemorrhage improves survival. The Journal of pharmacology and experimental therapeutics 347: 346-356.
25. Kabeya Y, Mizushima N, Ueno T, Yamamoto A, Kirisako T, et al. (2000) LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing. EMBO J 19: 5720-5728.
26. Klionsky DJ, Abeliovich H, Agostinis P, Agrawal DK, Aliev G, et al. (2008) Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes. Autophagy 4: 151-175.
27. Choi M-J, Jung KH, Kim D, Lee H, Zheng H-M, et al. (2011) Anti-cancer effects of a novel compound HS-113 on cell growth, apoptosis, and angiogenesis in human hepatocellular carcinoma cells. Cancer letters 306: 190-196.
28. Steele S, Brunton J, Ziehr B, Taft-Benz S, Moorman N, et al. (2013) Francisella tularensis harvests nutrients derived via ATG5-independent autophagy to support intracellular growth. PLoS Pathog 9: e1003562.
29. Shea FF, Rowell JL, Li Y, Chang TH, Alvarez CE (2012) Mammalian alpha arrestins link activated seven transmembrane receptors to Nedd4 family e3 ubiquitin ligases and interact with beta arrestins. PloS one 7: e50557.
30. Pankiv S, Clausen TH, Lamark T, Brech A, Bruun JA, et al. (2007) p62/SQSTM1 binds directly to Atg8/LC3 to facilitate degradation of ubiquitinated protein aggregates by autophagy. J Biol Chem 282: 24131-24145.
31. Adams BK, Cai J, Armstrong J, Herold M, Lu YJ, et al. (2005) EF24, a novel synthetic curcumin analog, induces apoptosis in cancer cells via a redoxdependent mechanism. Anti-Cancer Drugs 16: 263-275.
32. Selvendiran K, Tong L, Vishwanath S, Bratasz A, Trigg NJ, et al. (2007) EF24 induces G2/M arrest and apoptosis in cisplatin-resistant human ovarian cancer cells by increasing PTEN expression. J Biol Chem 282: 28609-28618.
33. Maiuri MC, Zalckvar E, Kimchi A, Kroemer G (2007) Self-eating and selfkilling: crosstalk between autophagy and apoptosis. Nat Rev Mol Cell Biol 8: 741-752.
34. Shingu T, Fujiwara K, Bögler O, Akiyama Y, Moritake K, et al. (2009) Inhibition of autophagy at a late stage enhances imatinib-induced cytotoxicity in human malignant glioma cells. Int J Cancer 124: 1060-1071.
35. Kanzawa T, Germano I, Komata T, Ito H, Kondo Y, et al. (2004) Role of autophagy in temozolomide-induced cytotoxicity for malignant glioma cells. Cell Death Differ 11: 448-457.
36. Okada H, Mak TW (2004) Pathways of apoptotic and non-apoptotic death in tumour cells. Nat Rev Cancer 4: 592-603.
37. Chen TS, Wang XP, Sun L, Wang LX, Xing D, et al. (2008) Taxol induces caspase-independent cytoplasmic vacuolization and cell death through endoplasmic reticulum (ER) swelling in ASTC-a-1 cells. Cancer Lett 270: 164-172.
38. Sy LK, Yan SC, Lok CN, Man RY, Che CM (2008) Timosaponin A-III induces autophagy preceding mitochondria-mediated apoptosis in HeLa cancer cells. Cancer Res 68: 10229-10237.
39. Bhanot H, Young AM, Overmeyer JH, Maltese WA (2010) Induction of nonapoptotic cell death by activated Ras requires inverse regulation of Rac1 and Arf6. Mol Cancer Res 8: 1358-1374.
40. Kyoko O, Yoko S, Katsuyuki I, Haruki S, Yoshihiro S (2011) Induction of an incomplete autophagic response by cancer-preventive geranylgeranoic acid (GGA) in a human hepatoma-derived cell line. Biochem J 440: 63-71.
41. Amaravadi RK, Lippincott-Schwartz J, Yin X-M, Weiss WA, Takebe N, et al. (2011) Principles and current strategies for targeting autophagy for cancer treatment. Clin Cancer Res 17: 654-666.